Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRYO CELL INTERNATIONAL INC Director's Dealing 2021

Aug 26, 2021

34715_dirs_2021-08-26_0cde0ea2-7f1b-4b46-89df-2f2004456c38.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CRYO CELL INTERNATIONAL INC (CCEL)
CIK: 0000862692
Period of Report: 2021-08-24

Reporting Person: Portnoy Mark L. (Director, Co-CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-08-24 Common Stock M 67816 $2.90 Acquired 787514 Direct
2021-08-24 Common Stock F 25500 $10.50 Disposed 762014 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-08-24 Stock Option $2.90 M 67816 Disposed 2021-08-31 Common Stock (67816) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 42266 Indirect
Common Stock 71529 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option $3.14 2026-04-15 Common Stock (59459) 59459 Direct
Stock Option $7.92 2028-03-08 Common Stock (20000) 20000 Direct
Stock Option $7.53 2029-08-30 Common Stock (22222) 22222 Direct
Stock Option $7.28 2029-12-20 Common Stock (20000) 20000 Direct

Footnotes

F1: Shares of Common Stock held by Capital Asset Fund #1 Limited Partnership, as to which Mark L. Portnoy may be deemed the beneficial owner as its general partner.

F2: Shares of common stock were withheld by the Company as payment for the exercise price of the common stock and associated tax liabilities.

F3: Stock options will vest 1/3 on the date of grant, 1/3 on December 1, 2020 and 1/3 on December 1, 2021.